NCI Financial Statements & Analysis
Complete financial statements for NCI including income statement, balance sheet, and cash flow statement. Analyze NCI's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | TTM Q3 '25 | TTM Q4 '25 | Change | Impact |
|---|---|---|---|---|
| Revenue | 334.37M | 332.05M | 0.7% | |
| Gross Profit | 85.70M | 92.02M | 7.4% | |
| Operating Income | 13.59M | 12.65M | 6.9% | |
| Net Income | 9.24M | 6.13M | 33.7% | |
| EPS | 1.56 | 1.51 | 3.4% | |
| EBITDA | 19.40M | 18.24M | 6.0% | |
| Gross Margin | 25.63% | 27.71% | 8.1% | |
| Operating Margin | 4.06% | 3.81% | 6.3% | |
| Net Income Margin | 2.76% | 1.85% | 33.2% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | TTM Q4 '25 | TTM Q3 '25 |
|---|---|---|
| Revenue | 332.05M | 334.37M |
| Gross Profit | 92.02M | 85.70M |
| Operating Income | 12.65M | 13.59M |
| Net Income | 6.13M | 9.24M |
| EPS | 1.51 | 1.56 |
| EBITDA | 18.24M | 19.40M |
| Gross Margin | 27.71% | 25.63% |
| Operating Margin | 3.81% | 4.06% |
| Net Income Margin | 1.85% | 2.76% |
| R&D Expenses | 0 | 0 |
Financial Metrics
Want to dive deeper into NCI's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics